A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence | Radiation Oncology | Full Text

A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence | Radiation Oncology | Full Text

A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence

The improvement of survival outcomes and the reduction of toxicities for esophageal squamous cell carcinoma (SCC) are still needed. We conducted a pilot study of concurrent chemoradiotherapy with weekly doceta...

Authors:Qi Liu, Yi Xia, Yun Chen, Junhua Zhang, Jiaying Deng and Kuaile Zhao

Citation:Radiation Oncology 2020 15:75

Content type:Research

Published on: 8 April 2020

• ViewFull Text
 
• ViewPDF